logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
S

Silvia Novello

university of turin

87H指数
1.0K论文数
4.8W被引数
收录论文 259
发表时间
logo
Lung Cancer Survivorship: Challenges and Care Needs肺癌生存者：挑战与护理需求
errCancers
IF4.4
err2026-09-04
err0
errOAAI
errMassimiliano Cani; Paolo Cotogni; Alessandra Greco; Giacomo Ronconi; Elisa Lombardi; Matteo Fracchiolla; Stefania Vallone; Maria Vittoria Pacchiana; Irene Capizzi; Valentina Bertaglia; Simona Carnio; Luisella Righi; Maurizio Balbi; Lorenzo Belluomini; Paolo Bironzo; Silvia Novello
err分享
err收藏
High Prevalence of Superficial Metastases Supports Percutaneous Ultrasound-Guided Biopsy for Diagnosis and Molecular Profiling of Advanced Lung Cancer: Results from a Prospective Cohort浅表转移的高发生率支持经皮超声引导活检用于晚期肺癌的诊断和分子分型：一项前瞻性队列研究的结果
errCancers
IF4.4
err2026-07-23
err0
errOAAI
errMarta Viscuso; Vanina Livi; Giovanni Sotgiu; Valeria Cetoretta; Alessandra Cancellieri; Mariangela Puci; Angelo Minucci; Emilio Bria; Federico Cappuzzo; Silvia Novello; Rocco Trisolini
err分享
err收藏
Cytisine for Smoking Cessation Within a Lung Cancer Screening Program: Results From the Italian RISP Trial异烟肼用于肺癌筛查项目中的戒烟：意大利RISP试验结果
errJournal of Thoracic Oncology
IF20.8
err2026-07-06
err0
errOAAI
errMassimiliano Cani; Daniela Bafunno; Francesca Caumo; Silvia Novello; Salvatore Cardellicchio; Vincenzo Cilenti; Elena Davoli; Edoardo Mercadante; Ciro Battiloro; Aldo Cammarota; Sandro Sironi; Vito Barbieri; Vito Ladisa; Roberto Boffi; Beatrice Cosentino; Mariam El Hayek; Ugo Pastorino
err分享
err收藏
Response to Letter Re: Real-World Outcomes of Immunotherapy Discontinuation at Two Years in Advanced Non-Small Cell Lung Cancer: final results of the ISTOP study.回复函：关于晚期非小细胞肺癌免疫疗法停药两年后的真实世界结局：ISTOP研究的最终结果。
errEuropean Journal of Cancer
IF7.1
err2026-05-02
err0
PREAI
errMaria Gemelli; Luca Sala; Alessandro Morabito; Vincenzo Sforza; Alessio Cortellini; Giulia La Cava; Federica Bertolini; Giorgia Guaitoli; Simona Carnio; Silvia Novello; Alessandro Leonetti; Marcello Tiseo; Francesca Mazzoni; Federica Cosso; Marianna Macerelli; Alexandro Membrino; Giulio Metro; Rita Chiari; Carlo Genova; Rossana Berardi
err分享
err收藏
Lung cancer in women: current evidence and future research priorities女性肺癌：当前证据和未来研究重点
errLung Cancer
IF4.4
err2026-01-04
err0
PREAI
errMonireh Sadat Seyyedsalehi; Massimiliano Cani; Qian Wang; Chitra Thakur; Umberto Malapelle; Chung Yin Kong; Silvia Novello; Paolo Boffetta
err分享
err收藏
Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50%PD-L1 ≥50%的晚期非小细胞肺癌患者，在初次免疫治疗原发性耐药后，采用疾病进展后联合铂类为基础的化疗的免疫治疗。
errESMO Open
IF8.3
err2025-11-17
err0
errOAAI
errA. De Giglio; L. Zullo; A. Di Federico; M. Cani; M. Aldea; D. Soldato; F.G. Dall’Olio; F. Mantuano; F. Sperandi; V. Favorito; A. Sadowska; L.E.L. Hendriks; T. Gorria; L. Mezquita; F. Tabbò; S. Novello; F. Gelsomino; B. Besse; A. Ardizzoni
err分享
err收藏
Clinical Characteristics and Surgical Outcomes of Patients Receiving Perioperative Pembrolizumab in KEYNOTE-671接受围手术期帕博利珠单抗治疗患者的临床特征与手术结局——KEYNOTE-671研究
errThe Annals of Thoracic Surgery
IF0
err2025-11-05
err0
PREAI
errMoishe Liberman; David R. Jones; Heather Wakelee; Shugeng Gao; Balazs Halmos; Ernest Nadal; Anna Łowczak; Martin Reck; Silvia Novello; Danielli Matias; Alexander Luft; Rina Hui; Se-Hoon Lee; Masahiro Tsuboi; Terufumi Kato; Yuming Zhu; Benny Weksler; Erin Jensen; Ayman Samkari; Steven M. Keller; Jonathan D. Spicer
err分享
err收藏
EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancerEORTC 1417 - REACTION：一项关于依托泊苷联合顺铂/卡铂，并联合或不联合帕博利珠单抗治疗初治广泛期小细胞肺癌的II期研究
errEuropean Journal of Cancer
IF7.1
err2025-10-30
err0
PREAI
errJessica Menis; Laurent Greiller; Pierre Demontrond; Isabelle Monnet; Silvia Novello; Lorenzo Livi; Robin Young; Chantal Decroisette; Nicolas Cloarec; Gilles Robinet; Roland Schott; Jerome Fayette; Giuseppe Luigi Banna; Filippo De Marinis; Raffaele Califano; Boris Duchemann; Andrea Luciani; Ida Colantonio; Beatrice Fournier; Yassin Pretzenbacher; Caroline Caramella; Mario Silva; Thierry Berghmans; Anne-Marie Dingemans; Paolo Bironzo; Jonathan Tugwood; Cong Zhou; Steven Hill; Kieran Bradbury; Karen Morris; Elaine Kilgour; Caroline Dive; Fiona Blackhall; Benjamin Besse
err分享
err收藏
Real-world outcomes of second-line carboplatin plus pemetrexed after first-line osimertinib in EGFR-mutant advanced NSCLC: An international multicentre cohort studyEGFR突变晚期非小细胞肺癌患者在接受一线奥希替尼治疗后，接受卡铂联合培美曲塞二线治疗的实际疗效：一项国际多中心队列研究
errLung Cancer
IF4.4
err2025-10-16
err0
PREAI
errIgor Gomez-Randulfe; Federico Monaca; Ornella Cantale; Maria Lucia Reale; Loredana Mrak; Lodovica Zullo; Sofia Silva Diaz; Marta Zaragoza Bueno; Marya Alejandra Maridueña Moreno; Charlotte Davis; Samantha Cox; Daniel Lee; Riyaz Shah; Tom Geldart; Javier Baena; Jose Carlos Benitez; M.A. Rosario Garcia Campelo; Jordi Remon; David Planchard; Domenico Galetta; Marcello Tiseo; Diego Cortinovis; Giulio Metro; Emilio Bria; Francesco Passiglia; Silvia Novello; Raffaele Califano
err分享
err收藏
Advanced-stage ALK-positive non–small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database晚期ALK阳性非小细胞肺癌（NSCLC）患者：来自意大利生物标志物ATLAS数据库的真实世界治疗模式与结果
errLung Cancer
IF4.4
err2025-09-24
err0
errOAAI
errMaria Lucia Reale; Daniela Scattolin; Antonio Vitale; Francesco Passiglia; Salvatore Grisanti; Marianna Macerelli; Domenico Galetta; Claudio Sini; Gabriele Minuti; Fabrizio Citarella; Elisa Roca; Francesco Agustoni; Alessandra Dodi; Diego Cortinovis; Lorenzo Belluomini; Serena Ricciardi; Antonello Veccia; Elio Gregory Pizzutilo; Vieri Scotti; Greta Alì; Francesca Mazzoni; Alessandro Russo; Daniele Pignataro; Alessandra Bulotta; Pierluigi Piovano; Concetta Sergi; Anna Bettini; Carlo Genova; Alberto Pavan; Hector José Soto Parra; Cinzia Ortega; Daniele Pozzessere; Tiziana Vavalà; Rita Chiari; Cristina Zannori; Alessandro D’Aveni; Giulia Meoni; Diana Giannarelli; Umberto Malapelle; Silvia Novello; Emilio Bria; Giulia Pasello
err分享
err收藏
Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial仑伐替尼联合帕博利珠单抗治疗经治性转移性B3胸腺瘤和胸腺癌（PECATI）：一项单臂、II期临床试验
errlancet oncology
IF0
err2025-09-01
err0
PREAI
errJordi Remon; Paolo Bironzo; Nicolas Girard; Laurence Bigay-Game; Oscar Juan-Vidal; Javier de Castro; Noemí Reguart; Laurent Greillier; Sophie Cousin; Eric Dansin; Margarita Majem; Reyes Bernabé; Joaquin Mosquera Martinez; Marta Díaz; Alba Meya; Daniel Alcalá-López; Alicia García-Sanz; Luisella Righi; Silvia Novello; Benjamin Besse
err分享
err收藏
Consolidation thoracic radiotherapy after chemoimmunotherapy in ES-SCLC: A multicentric retrospective analysis化疗免疫治疗后的小细胞肺癌的巩固性胸放射治疗：一项多中心回顾性分析
errEuropean Journal of Cancer
IF7.1
err2025-06-25
err0
PREAI
errFederico Monaca; Igor Gomez-Randulfe; Gerard Walls; Ornella Cantale; Ana Parreira; Sara Polidori; Mariantonietta Di Salvatore; Vito Longo; Domenico Galetta; Emanuele Vita; Antonella Martino; Maria Antonietta Gambacorta; Luca Boldrini; Yvonne Summers; Giampaolo Tortora; Fiona Blackhall; Silvia Novello; Clara Chan; Emilio Bria; Corinne Faivre-Finn; Raffaele Califano
err分享
err收藏
The effects of race on anti-PD-(L)1 monoclonal antibodies in non-small cell lung cancer: A systematic literature review and meta-analysis种族对非小细胞肺癌中抗PD-(L)1单克隆抗体的影响：一项系统文献综述和荟萃分析
errcritical reviews in oncology hematology
IF0
err2025-06-18
err0
PREAI
errCarlo Genova; Federico Cappuzzo; Giorgio Minotti; Nicola Normanno; Barry Rodgers-Gray; Nicola Waghorne; Silvia Novello; Marcello Tiseo
err分享
err收藏
Impact of Tumor Response and Response Duration on Survival Among Participants Receiving Pembrolizumab Plus Chemotherapy as First-Line Therapy for Non-Small-Cell Lung Cancer接受帕博利珠单抗联合化疗作为非小细胞肺癌一线治疗的患者中，肿瘤应答和应答持续时间对生存的影响
errOncology and Therapy
IF3.2
err2025-06-11
err0
errOAAI
errMarina C. Garassino; Ying Cheng; Delvys Rodriguez-Abreu; Silvia Novello; Julien Mazieres; Andrew G. Robinson; Steven F. Powell; Balazs Halmos; Jhanelle E. Gray; Meihua Wang; Cong Chen; Jing Yang; Fabricio Souza; Paul Schwarzenberger; Luis Paz-Ares
err分享
err收藏
A prospective study on clinicians' attitudes and survival outcomes for patients with advanced NSCLC and poor performance status in the immunotherapy era: PICASO (GOIRC-04-2020)一项关于免疫治疗时代下，临床医生对晚期非小细胞肺癌（NSCLC）及体力状态较差患者的态度与生存结局的前瞻性研究：PICASO（GOIRC-04-2020）。
errLUNG CANCER
IF4.4
err2025-06-01
err0
PREAI
errFacchinetti, Francesco; Camerini, Andrea; Bennati, Chiara; Bordi, Paola; De Carlo, Elisa; Mazzoni, Francesca; Metro, Giulio; Bertolini, Federica; Longo, Lucia; Ricciardi, Serena; Pilotto, Sara; Giardina, Donatella; Passiglia, Francesco; Scotti, Vieri; Piacentini, Paolo; Frega, Stefano; Calabro, Luana; Guida, Annalisa; Grosso, Maria Antonietta; Longobardi, Jenny; Merlini, Alessandra; Cosso, Federica; Leonetti, Alessandro; Gariazzo, Eleonora; Guaitoli, Giorgia; Belluomini, Lorenzo; Bearz, Alessandra; Tognetto, Michele; Bria, Emilio; Cortinovis, Diego Luigi; Novello, Silvia; Di Maio, Massimo; Tiseo, Marcello
err分享
err收藏
Ecteinascidin synthetic analogues: a new class of selective inhibitors of transcription, exerting immunogenic cell death in refractory malignant pleural mesotheliomaEcteinascidin合成类似物: 一类新的选择性转录抑制剂，在难治性恶性胸膜间皮瘤中引起免疫原性细胞死亡
errJOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
IF12.8
err2024-12-21
err0
errOAAI
errSalaroglio, I. C.; Aviles, P.; Kopecka, J.; Merlini, A.; Napoli, F.; Righi, L.; Novello, S.; Sullivan, H.; Cuevas, C.; Scagliotti, G. V.; Riganti, C.
err分享
err收藏
RELAY: Final Overall Survival for Erlotinib Plus Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLCRELAY研究：厄洛替尼联合ramucirumab或安慰剂在未治疗、EGFR突变型转移性NSCLC中的最终总生存期
errJOURNAL OF THORACIC ONCOLOGY
IF20.8
err2024-11-01
err5
PREAI
errNakagawa, Kazuhiko; Garon, Edward B.; Seto, Takashi; Nishio, Makoto; Aix, Santiago Ponce; Paz-Ares, Luis; Chiu, Chao-Hua; Park, Keunchil; Novello, Silvia; Nadal, Ernest; Nishino, Kazumi; Yoh, Kiyotaka; Shih, Jin-Yuan; Chik, Jeannie Y. K.; Moro-Sibilot, Denis; Puri, Tarun; Varughese, Sunoj Chacko; Frimodt-Moller, Bente; Visseren-Grul, Carla; Reck, Martin
err分享
err收藏
IMpower010: ctDNA status and 5y DFS follow up in patients (pts) with resected NSCLC who received adjuvant chemotherapy (chemo) followed by atezolizumab (atezo) or best supportive care (BSC)IMpower010：可切除非小细胞肺癌（NSCLC）患者接受辅助化疗（chemo）后，采用阿替利珠单抗（atezo）或最佳支持治疗（BSC）的循环肿瘤DNA（ctDNA）状态与5年无病生存率（DFS）随访情况
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err1
PREAI
errWakelee, H.; Reck, M.; Felip, E.; Altorki, N. K.; Vallieres, E.; Liersch, R.; Oizumi, S.; Tanaka, H.; Hamm, J. T.; McCune, S.; Bennett, E.; Gitlitz, B. J.; McNally, V. A.; Novello, S.; Ballinger, M.; Zou, W.; Nabet, B.; Srivastava, M.; Zhou, C.
err分享
err收藏
Advanced ALK-positive non-small cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database晚期ALK阳性非小细胞肺癌（NSCLC）患者：来自意大利生物标志物ATLAS数据库的真实世界治疗模式与结果
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errReale, M. L.; Scattolin, D.; Bria, E.; Vitale, A.; Grisanti, S.; Costa, J.; Galetta, D.; Sini, C.; Minuti, G.; Citarella, F.; Roca, E.; Agustoni, F.; Tiseo, M.; Cortinovis, D. L.; Pilotto, S.; Ricciardi, S.; Passiglia, F.; Malapelle, U.; Novello, S.; Pasello, G.
err分享
err收藏
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial在早期非小细胞肺癌患者中，新辅助派姆单抗加化疗后辅助派姆单抗与单独新辅助化疗的比较 (KEYNOTE-671): 一项随机，双盲，安慰剂对照的3期试验
errLANCET
IF88.5
err2024-09-01
err4
PREAI
errSpicer, Jonathan D.; Garassino, Marina C.; Wakelee, Heather; Liberman, Moishe; Kato, Terufumi; Tsuboi, Masahiro; Lee, Se-Hoon; Chen, Ke-Neng; Dooms, Christophe; Majem, Margarita; Eigendorff, Ekkehard; Martinengo, Gaston L.; Bylicki, Olivier; Rodriguez-Abreu, Delvys; Chaft, Jamie E.; Novello, Silvia; Yang, Jing; Arunachalam, Ashwini; Keller, Steven M.; Samkari, Ayman; Gao, Shugeng
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
P
Pasi A. Jänne
H 指数: 163 · 论文数: 2.3K
J
James Chih‐Hsin Yang
H 指数: 141 · 论文数: 1.2K
T
Tony Mok
H 指数: 131 · 论文数: 1.1K
E
Enriqueta Felip
H 指数: 129 · 论文数: 1.5K
J
Jean‐Charles Soria
H 指数: 128 · 论文数: 1.6K
查看更多